Skip to main content
FinSpry Logo
FinSpry
DXCM logo
DXCM
(NASDAQ)
DexCom, Inc.
$70.48-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

DexCom (DXCM) Stock Price & Financial Analysis

DexCom Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$70.28 - $71.43
52-Week High$89.98
52-Week Low$54.11
Open$71.08
Volume3.20M
Average Volume (3M)4.91M
Market Cap29.42B
Shares Outstanding393.60M
P/E Ratio (TTM)32.99
Forward P/E19.38
Price to Sales (P/S)6.37
Price to Book (P/B)10.38
EV/EBITDA21.09
Revenue (TTM)4.82B
Net Income (TTM)930.40M
Free Cash Flow (TTM)1.43B
EPS (TTM)$2.31
Profit Margin19.31%
Operating Margin21.45%
Return on Equity (ROE)31.47%
Debt to Equity0.43
50-Day MA$70.48
200-Day MA$67.35
52-Week Change-7.28%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About DexCom

What is the current stock price for DXCM?

As of the latest trading session, DXCM stock trades at $70.48. The 52-week range is $54.11–$89.98, with a day range of $70.28–$71.43.

What is the P/E ratio for DXCM?

DexCom's trailing P/E ratio is 33.0, meaning investors pay $33.0 for every $1 of annual earnings. The forward P/E is 19.4, reflecting analyst expectations for future earnings. DexCom operates in the Healthcare sector.

Does DXCM pay dividends?

DexCom does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for DXCM?

Based on 27 analysts, the consensus for DXCM is Buy.

What is the market cap of DXCM?

DexCom's market capitalization is $27.74B, classifying it as a large-cap company. DexCom operates in the Healthcare sector within the Medical Devices industry.